Press Releases

A survey from the GW Cancer Center highlights the influence of supportive oncodermatology on patient quality of life.

The D.C. Government, GW’s Academic Medical Enterprise, and Universal Health Services have finalized a non-binding memorandum of agreement to enter into negotiations to support the establishment and operation of a hospital and health care services on the St. Elizabeths campus in Southeast, D.C.

The GW Medical Enterprise will begin drive-through testing for COVID-19 on Monday, April 6, 2020.

A new literature review from scientists at GW and NIST suggests that nutrition and diet have a profound impact on the microbial composition of the gut.

Researchers at GW published in the Journal of Clinical Oncology Clinical Cancer Informatics on the new knowledgebase OncoMX, which will improve the exploration and research of cancer biomarkers in the context of related evidence.

Physician-researchers at the George Washington University published a review suggesting that telehealth interventions are associated with improved obstetric outcomes.

Research from the George Washington University has found that apolipoprotein A-I binding protein restricts HIV-1 replication by targeting lipid rafts and reducing virus-cell fusion.

A new survey from dermatology and emergency medicine researchers at GW suggests that the dermatology community is inadequately prepared for a biological disaster and would benefit from a formal preparedness training program.

The Cutaneous Oncology Program at the GW Cancer Center was selected as the first global site for a clinical trial for patients with high-risk cutaneous squamous cell carcinoma.

A new study from Jonathan Silverberg, MD, PhD, MPH, maternal depression in the postpartum period, and even beyond, is associated with the development of atopic dermatitis throughout childhood and adolescence.